Check, Mate
"Check, Mate" follows two lifelong friends as they navigate the challenges of memory loss, highlighting the power of early cognitive screening and how one simple conversation can change everything. Alzheimer's doesn't just take memories — it reshapes lives, relationships, and futures. Early detection opens the door to treatment, planning, and hope.
For the first time in history, treatments exist that can meaningfully slow the progression of Alzheimer's disease — but they only work in the early stages. That makes early detection not just important, but urgent. The VoA Foundation is committed to raising awareness, advancing education, and ensuring that patients, caregivers, and healthcare providers have the tools and information they need to act early.
Why Early Detection Matters
Two FDA-approved treatments — Leqembi and Kisunla — can slow Alzheimer's progression, but are only available to early-stage patients
Blood tests can now help detect Alzheimer's, making screening faster and more accessible than ever before
Medicare covers a free cognitive evaluation at the Annual Wellness Visit for patients 65 and older — but most patients don't receive one unless they ask
Alzheimer's is NOT a normal part of aging — it is a disease, and the earlier it is detected, the more options patients have
A New Era for Early Detection
A quick cognitive checkup can make a big difference, helping older adults catch problems early, stay independent longer, and access new treatments. Voices of Alzheimer’s has published both a scientific article in the Journal of Internal Medicine and an easy-to-understand summary to explain why early detection matters and how primary care providers can help lead the way.